Medicine guide
Amjevita
80 mg/.8mL · Injection
- Prescription only
- Tumor Necrosis Factor Blocker
- Active substance
- Adalimumab-Atto
- Made by
- Nuvaila Limited
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Medicine groupCancer treatments and immune-system medicines
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | Nuvaila Limited |
|---|---|
| Active substance | Adalimumab-Atto |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 80 mg/.8mL |
| Form | Injection |
| Route | Subcutaneous |
| Packs | 1 SYRINGE in 1 CARTON / .8 mL in 1 SYRINGE · 2 SYRINGE in 1 CARTON / .8 mL in 1 SYRINGE |
| NDC | 84612-481 |
Source: NDC Directory · 2026-09-13 · not reviewed by a clinician
Source: US Food and Drug Administration, NDC Directory. Reuse terms: US government work (FDA).
Other strengths and forms
13 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- Injection13 products
- 10 mg/.2mL
20 mg/.2mL3
20 mg/.2mL · 3 companies
- 20 mg/.4mL
40 mg/.8mL2
40 mg/.8mL · 2 companies
40 mg/.4mL3
40 mg/.4mL · 3 companies
80 mg/.8mL3
80 mg/.8mL · 3 companies
- Amgen USA Inc.
- Amgen, Inc
- Nuvaila Limited · this page
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.
Amjevita20 mg/.2mLPrescription only Amgen, Inc · Adalimumab-AttoAmjevita40 mg/.8mLPrescription only Amgen, Inc · Adalimumab-AttoAmjevita20 mg/.4mLPrescription only Amgen, Inc · Adalimumab-AttoAmjevita10 mg/.2mLPrescription only Amgen, Inc · Adalimumab-AttoAmjevita40 mg/.4mLPrescription only Amgen, Inc · Adalimumab-AttoAmjevita80 mg/.8mLPrescription only Amgen, Inc · Adalimumab-Atto